Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
56,642,643
-
Share change
-
+4,951,206
-
Total reported value
-
$795,035,114
-
Put/Call ratio
-
15%
-
Price per share
-
$14.04
-
Number of holders
-
251
-
Value change
-
+$69,132,475
-
Number of buys
-
110
-
Number of sells
-
113
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2022
As of 30 Jun 2022,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
251 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,642,643 shares.
The largest 10 holders included
Mondrian Investment Partners LTD, MORGAN STANLEY, MACQUARIE GROUP LTD, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, BlackRock Inc., BRANDES INVESTMENT PARTNERS, LP, VAN ECK ASSOCIATES CORP, and FMR LLC.
This page lists
255
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.